Pemphigoid diseases are a group of well defined autoimmune disorders that are
characterised by autoantibodies against structural proteins of the dermal–epidermal junction …

Objective We aimed to develop consensus-based recommendations for streamlining
medical communication among various health care professionals, to improve accuracy of …

Bullous pemphigoid (BP) is a type 2 inflammation-and immunity-driven skin disease, yet a
comprehensive understanding of the immune landscape, particularly immune-stromal …

Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal blistering disease
provoked by autoantibodies directed against two hemidesmosomal proteins: BP180 and …

Background Bullous pemphigoid (BP) is an autoimmune blistering disorder that
predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are …

Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is
characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous …

Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

Pemphigus vulgaris (PV) and bullous pemphigoid (BP) are autoantibody-mediated diseases
clinically characterized by blisters and erosions of skin and/or mucous membranes. Immune …

Lichen planus pemphigoides (LPP) is a very rare autoimmune sub-epidermal blistering
disease associated with lichenoid skin changes. Initially thought to be a mere variant of …

Bullous pemphigoid (BP) constitutes the most frequent autoimmune subepidermal blistering
disease. It is associated with autoantibodies directed against the BP antigens 180 (BP180 …